Abstract
The application of the peptide-linked β2-microglobulin (β2m) strategy is limited in some cases due to the incompatibility between the sequences of the peptides and the restriction sites of the plasmid vectors. An isocaudamer technique was adapted to overcome this restriction. Three peptide-linked β2m genes, HBc18–27-hβ2m gene, OVA257–264-mβ2m gene and HER2/neu369–377-mβ2m gene, were inserted into the pET28a vectors with this technique. The corresponding proteins were expressed in Escherichia coli with yields of over 50 mg/l culture and purities of over 80%. This strategy facilitates the construction of peptide-linked β2m molecules and will simplify the preparation of major histocompatibility complex-peptide complexes.
Similar content being viewed by others
References
Cai QL, Wei F, Lin YH et al (2004) Immunogenicity of polyepitope libraries assembled by epitope shuffling: an approach to the development of chimeric gene vaccination against malaria. Vaccine 23:267–277
Garboczi DN, Hung DT, Wiley DC (1992) HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc Natl Acad Sci USA 89:3429–3433
Gileadi O, Burgess-Brown NA, Colebrook SM et al (2008) High throughput production of recombinant human proteins for crystallography. In: Kobe B, Guss M, Huber T (eds) Structural proteomics: high-throughput methods. Totowa, New Jersey, pp 221–246
Mierendorf RC, Morris BB, Hammer B et al (1998) Expression and purification of recombinant proteins using the pET system. In: Reischl U (ed) Molecular diagnosis of infectious diseases. Totowa, New Jersey, pp 257–292
Shen C, Chang CC, Zhang J et al (2006) Structural and functional characterization of peptide-beta2m fused HLA-A2/MART1(27–35) complexes. Biochem Biophys Res Commun 342:57–65
Tafuro S, Meier UC, Dunbar PR et al (2001) Reconstitution of antigen presentation in HLA class I-negative cancer cells with peptide-beta2m fusion molecules. Eur J Immunol 31:440–449
Uger RA, Barber BH (1998) Creating CTL targets with epitope-linked beta 2-microglobulin constructs. J Immunol 160:1598–1605
Uger RA, Chan SM, Barber BH (1999) Covalent linkage to beta2-microglobulin enhances the MHC stability and antigenicity of suboptimal CTL epitopes. J Immunol 162:6024–6028
White J, Crawford F, Fremont D et al (1999) Soluble class I MHC with beta2-microglobulin covalently linked peptides: specific binding to a T cell hybridoma. J Immunol 162:2671–2676
Zhong Z, Xu Z, Peng L et al (2006) Tandem repeat mhBD2 gene enhance the soluble fusion expression of hBD2 in Escherichia coli. Appl Microbiol Biotechnol 71:661–667
Zhou L, Lai ZT, Lu MK et al (2008) Expression and hydroxylamine cleavage of thymosin alpha 1 concatemer. J Biomed Biotechnol 2008:736060–736067
Acknowledgments
This work was supported in part by the grants from the National Nature Science Foundation of China (30571703) and National Science Fund for Distinguished Young Scholars of China (30325017).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Meng, F., Shen, C., He, Y. et al. Cloning and expression of three peptide-linked β2-microglobulin molecules in Escherichia coli with an isocaudamer technique. Biotechnol Lett 31, 831–836 (2009). https://doi.org/10.1007/s10529-009-9950-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-009-9950-3